TMCnet News
RC21X Receives Investment From Stadia VenturesCORAOPOLIS, Penn., April 11, 2017 /PRNewswire/ -- Stadia Ventures, the St. Louis-based sports business accelerator, announced today that it was investing in RC21X and its platforms for monitoring brain performance. RC21X is one of five companies selected for Stadia's Spring 2017 Cohort and an investment of up to $100,000 in exchange for an undisclosed equity stake. The accelerator received nearly 200 applications from around the world for this most recent class. "We're very excited about this investment and the partnership opportunities it brings," says RC21X CEO Clarence Carlos. "Stadia has assembled an impressive portfolio over the years. The mentoring and coaching that comes with this selection is going to help us to be a better performing company for our investors and for our customers." Stadia Accelerator helps established sports business startups get to the next level through the combination of up to a $100,000 equity investment, intensive mentoring, and connecting founders to the top sports business executives in the country. Stadia leverages its network of industry executives that includes senior leadership at teams, leagues, sponsors, manufacturers, marketers, investors and business service representatives. RC21X and the mobile app Roberto are based on pen-and-paper tests that have been used for decades to monitor neurocognitive and neuro-motor performance. Each session produces a unique Brain Performance Profile—a set of scores that provides objective data on brain performance. Users can monitor the effects of those changes in real time, allowing the opportunity to have more meaningful conversations with healthcare providers if their performance shows a downward trend. The other new startups in Stadia's portfolio are based in the Los Angeles area and in Israel:
"With the coaching and support we get through this program, we're going to be able to help a lot of people," says Carlos. "Our tools will allow athletes and their families to have unprecedented access to objective data on their brain performance. Armed with that data, they can make better decisions regarding their brain health." (30) About RC21X Coraopolis, PA-based RC21X (named after Roberto Clemente)—teamed with the Human Performance Institute at the University of Texas at Arlington. Incorporating science and scoring algorithms from Dr. George Kondraske, the team put together a tool that gives objective data in real-time about how well your brain is performing. The company's brain performance monitoring program is being rolled out at more than 2,000 NovaCare Physical Therapy (www.novacare.com) facilities nationwide. For more information visit: www.RC21X.com. About Stadia Ventures Stadia Ventures is the Sports Innovation Hub with headquarters in St. Louis, MO. and connects business professionals who share a passion for sports and a need for resources – from capital and networking to education and mentorship. For more information visit: www.stadiaventures.com. For more information, please contact Chris Fletcher at 412-400-1428 or email at [email protected]. Available for interviews Clarence Carlos, CEO: Developed RC21X vision and concept; Founder of MedLogic, negotiated exclusive, U.S. license with device manufacturer Mark Cavicchia, Chief Digital Officer: Founder of WhereverTV; More than 20 years developing web-based consumer products Gus Frerotte, VP of Brain Health Initiatives: 15-year NFL veteran and coach. Leads outreach initiatives to wellness and sports organizations Related Links Related Video This content was issued through the press release distribution service at Newswire.com. For more info visit: http://www.newswire.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/rc21x-receives-investment-from-stadia-ventures-300437853.html SOURCE RC21X 
|